| 1 |
34597653 | Combination of Compound Kushen Injection and cisplatin shows synergistic antitumor activity in p53-R273H/P309S mutant colorectal cancer cells through inducing apoptosis. | 2022 Jan 30 |
1 |
| 2 |
34994335 | Novel coumarin derivatives containing a triazole moiety: A study on synthesis, cytotoxicity, membrane dysfunction, apoptosis, cell cycle, and antiangiogenic studies. | 2022 Jan 6 |
1 |
| 3 |
34995485 | Caffeic acid phenethyl ester targets ubiquitin-specific protease 8 and synergizes with cisplatin in endometrioid ovarian carcinoma cells. | 2022 Mar |
1 |
| 4 |
35073843 | Epigenetic landscape of drug responses revealed through large-scale ChIP-seq data analyses. | 2022 Jan 24 |
1 |
| 5 |
35167826 | Cisplatin toxicity in the developing brain displays an absolute requirement for caspase-3. | 2022 May |
1 |
| 6 |
35205642 | Activation of ABCC Genes by Cisplatin Depends on the CoREST Occurrence at Their Promoters in A549 and MDA-MB-231 Cell Lines. | 2022 Feb 11 |
1 |
| 7 |
35328718 | p62 Promotes the Mitochondrial Localization of p53 through Its UBA Domain and Participates in Regulating the Sensitivity of Ovarian Cancer Cells to Cisplatin. | 2022 Mar 18 |
3 |
| 8 |
35346500 | NDC80 Enhances Cisplatin-resistance in Triple-negative Breast Cancer. | 2022 Jun |
1 |
| 9 |
35456022 | Apoptotic and DNA Damage Effect of 1,2,3,4,6-Penta-O-galloyl-beta-D-glucose in Cisplatin-Resistant Non-Small Lung Cancer Cells via Phosphorylation of H2AX, CHK2 and p53. | 2022 Apr 14 |
1 |
| 10 |
35468881 | JMJD2C mediates the MDM2/p53/IL5RA axis to promote CDDP resistance in uveal melanoma. | 2022 Apr 25 |
1 |
| 11 |
35487028 | New insights into the interactions of HPV-16 E6*I and E6*II with p53 isoforms and induction of apoptosis in cancer-derived cell lines. | 2022 Jun |
3 |
| 12 |
35522909 | Exosome-transmitted miR-769-5p confers cisplatin resistance and progression in gastric cancer by targeting CASP9 and promoting the ubiquitination degradation of p53. | 2022 May |
2 |
| 13 |
35608342 | A Critical Role for p53 during the HPV16 Life Cycle. | 2022 May 24 |
1 |
| 14 |
35636434 | Melatonin Increases the Sensitivity of Osteosarcoma Cells to Chemotherapy Drug Cisplatin. | 2022 May 30 |
2 |
| 15 |
32757802 | Apigenin Enhanced Antitumor Effect of Cisplatin in Lung Cancer via Inhibition of Cancer Stem Cells. | 2021 |
5 |
| 16 |
33183422 | Effect of Nano-Platinum on Proliferation and Apoptosis of Non-Small Cell Lung Cancer Cells via P53 Pathway. | 2021 Feb 1 |
1 |
| 17 |
33240412 | Blockade of TRIM59 enhances esophageal cancer cell chemosensitivity to cisplatin by upregulating p53. | 2021 Jan |
4 |
| 18 |
33390811 | LncRNA XIST acts as a MicroRNA-520 sponge to regulate the Cisplatin resistance in NSCLC cells by mediating BAX through CeRNA network. | 2021 |
1 |
| 19 |
33456714 | Correction: Cepharanthine hydrochloride reverses the mdr1 (P-glycoprotein)-mediated esophageal squamous cell carcinoma cell cisplatin resistance through JNK and p53 signals. | 2021 Jan 5 |
1 |
| 20 |
33473103 | p53 is required for nuclear but not mitochondrial DNA damage-induced degeneration. | 2021 Jan 20 |
1 |
| 21 |
33530952 | Inhibition of Kpnβ1 mediated nuclear import enhances cisplatin chemosensitivity in cervical cancer. | 2021 Feb 2 |
1 |
| 22 |
33627632 | Mutant p53 promotes RCP-dependent chemoresistance coinciding with increased delivery of P-glycoprotein to the plasma membrane. | 2021 Feb 24 |
1 |
| 23 |
33650658 | Circadian clock protein CRY1 prevents paclitaxel‑induced senescence of bladder cancer cells by promoting p53 degradation. | 2021 Mar |
1 |
| 24 |
33669781 | Mechanisms of Cisplatin in Combination with Repurposed Drugs against Human Endometrial Carcinoma Cells. | 2021 Feb 19 |
1 |
| 25 |
33705152 | Synergistic Therapy for Cervical Cancer by Codelivery of Cisplatin and JQ1 Inhibiting Plk1-Mutant Trp53 Axis. | 2021 Mar 24 |
1 |
| 26 |
33773191 | Bibenzyl analogue DS-1 inhibits MDM2-mediated p53 degradation and sensitizes apoptosis in lung cancer cells. | 2021 May |
2 |
| 27 |
33850897 | A metabolism-related gene signature for predicting the prognosis and therapeutic responses in patients with hepatocellular carcinoma. | 2021 Mar |
1 |
| 28 |
33868388 | Interplay Between Thiamine and p53/p21 Axes Affects Antiproliferative Action of Cisplatin in Lung Adenocarcinoma Cells by Changing Metabolism of 2-Oxoglutarate/Glutamate. | 2021 |
4 |
| 29 |
33906321 | Epigallocatechin Gallate Enhances Inhibition Effect of DDP on the Proliferation of Gastric Cancer BGC-823 Cells by Regulating p19Arf-p53-p21Cip1 Signaling Pathway. | 2021 Apr 1 |
1 |
| 30 |
33907694 | Rapidly Progressing Urothelial Carcinoma Due to a Rare TP53 (p.Arg110Pro) Mutation: A Case Report and Review of the Literature. | 2021 |
1 |
| 31 |
33922989 | Platinum Complexes in Colorectal Cancer and Other Solid Tumors. | 2021 Apr 25 |
1 |
| 32 |
33952795 | Inhibitory Effect of Astragalus Polysaccharide Combined with Cisplatin on Cell Cycle and Migration of Nasopharyngeal Carcinoma Cell Lines. | 2021 Jul 1 |
1 |
| 33 |
33990641 | trans-Fatty acids promote p53-dependent apoptosis triggered by cisplatin-induced DNA interstrand crosslinks via the Nox-RIP1-ASK1-MAPK pathway. | 2021 May 14 |
3 |
| 34 |
34063628 | Jorunnamycin A Suppresses Stem-Like Phenotypes and Sensitizes Cisplatin-Induced Apoptosis in Cancer Stem-Like Cell-Enriched Spheroids of Human Lung Cancer Cells. | 2021 May 3 |
1 |
| 35 |
34165168 | MicroRNA‑10b modulates cisplatin tolerance by targeting p53 directly in lung cancer cells. | 2021 Aug |
7 |
| 36 |
34183962 | The Synergistic Combination of Cisplatin and Piperine Induces Apoptosis in MCF-7 Cell Line. | 2021 May |
3 |
| 37 |
34204834 | Resveratrol Modulation of Apoptosis and Cell Cycle Response to Cisplatin in Head and Neck Cancer Cell Lines. | 2021 Jun 12 |
2 |
| 38 |
34212455 | Antitumor effect of WEE1 blockade as monotherapy or in combination with cisplatin in urothelial cancer. | 2021 Sep |
5 |
| 39 |
34261004 | Cisplatin's potential for type 2 diabetes repositioning by inhibiting CDKN1A, FAS, and SESN1. | 2021 Aug |
1 |
| 40 |
34281219 | The Enigmatic Role of TP53 in Germ Cell Tumours: Are We Missing Something? | 2021 Jul 2 |
3 |
| 41 |
34445588 | Molecular Mechanisms of Chemoresistance Induced by Cisplatin in NSCLC Cancer Therapy. | 2021 Aug 18 |
2 |
| 42 |
34528900 | Metformin-induced chemosensitization to cisplatin depends on P53 status and is inhibited by Jarid1b overexpression in non-small cell lung cancer cells. | 2021 Sep 16 |
5 |
| 43 |
34731023 | Cisplatin Chemotherapy and Cochlear Damage: Otoprotective and Chemosensitization Properties of Polyphenols. | 2021 Dec 17 |
1 |
| 44 |
34769213 | The Role of TP53 in Cisplatin Resistance in Mediastinal and Testicular Germ Cell Tumors. | 2021 Oct 29 |
5 |
| 45 |
34822033 | USP39 attenuates the antitumor activity of cisplatin on colon cancer cells dependent on p53. | 2021 Nov 25 |
4 |
| 46 |
34832966 | In Vitro Assessment of the Role of p53 on Chemotherapy Treatments in Neuroblastoma Cell Lines. | 2021 Nov 19 |
1 |
| 47 |
34876239 | Comparison of cisplatin-induced anti-tumor response in CT26 syngeneic tumors of three BALB/c substrains. | 2021 Dec 8 |
1 |
| 48 |
34915755 | A nano based approach to alleviate cisplatin induced nephrotoxicity. | 2021 Jan-Dec |
1 |
| 49 |
35070983 | Prediction of the Mechanisms by Which Quercetin Enhances Cisplatin Action in Cervical Cancer: A Network Pharmacology Study and Experimental Validation. | 2021 |
1 |
| 50 |
31841768 | Towards the overcoming of anticancer drug resistance mediated by p53 mutations. | 2020 Mar |
1 |